Summary
Signal counts
Assets tracked: 1
Watchlist assets: 0
Registry stop assets: 0
Sponsor overview
MBrace Therapeutics
Public clinical-program risk signals across linked oncology Phase 2 assets for this sponsor.
Evidence links
Public sources
https://clinicaltrials.gov/study/NCT07145255 | https://clinicaltrials.gov/study/NCT07394218
Assets
Linked programs
- ADC: Low Signal (0/5)